Prosecution Insights
Prosecution Insights
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| §102 only | 1 (20%) |
| Double-patenting only | 1 (20%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OH, TAYLOR V | 1 | 81.2% | +15.3% |
| SHIM, DAVID M. | 1 | 57.8% | +55.9% |
| BARSKY, JARED | 1 | 50.3% | +23.1% |
| HEITMEIER, KENDALL NICOLE | 1 | 63.9% | +41.7% |
| NOLAN, JASON MICHAEL | 1 | 66.3% | -28.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18294510 | A PHARMACEUTICAL COMBINATION AND USE THEREOF | OH, TAYLOR V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18269301 | METHODS OF TREATING MULTIPLE SCLEROSIS | SHIM, DAVID M. | 51d overdue |
| 17921257 | METHODS FOR SYNTHESIZING N-(PHENYLSULFONYL)BENZAMIDE COMPOUNDS AND INTERMEDIATES THEREOF | HEITMEIER, KENDALL NICOLE | 2d overdue |
| 18294510 | A PHARMACEUTICAL COMBINATION AND USE THEREOF | OH, TAYLOR V | — |
| 18006494 | COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | BARSKY, JARED | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1626 | 1 |
| 1628 | 1 |
| 1621 | 1 |
| 1600 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18294510 | A PHARMACEUTICAL COMBINATION AND USE THEREOF | OH, TAYLOR V | 1625 | §102§112 | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18269301 | METHODS OF TREATING MULTIPLE SCLEROSIS | SHIM, DAVID M. | 1626 | §103 | Final Rejection | 51d overdue | Pending | Jun 23, 2023 |
| 18006494 | COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | BARSKY, JARED | 1628 | §103 | Non-Final OA | — | Pending | Jan 23, 2023 |
| 17921257 | METHODS FOR SYNTHESIZING N-(PHENYLSULFONYL)BENZAMIDE COMPOUNDS AND INTERMEDIATES THEREOF | HEITMEIER, KENDALL NICOLE | 1621 | §102 | Final Rejection | 2d overdue | Pending | Oct 25, 2022 |
| 17918557 | NOVEL MEDICAL USE OF MDM2 INHIBITORS | NOLAN, JASON MICHAEL | 1600 | DP | Final Rejection | — | Pending | Oct 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial